Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00819026 · ClinicalTrials.gov registry record

Observational Trial of Hepatitis C Virus Infected Patients on Calcineurin Inhibitors

A clinical trial, sponsored by University of Wisconsin, Madison.

Completed
Registry status
15
Enrollment target

NCT00819026 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 15 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00819026 has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
15 participants
Enrollment target

Study Summary

Hepatitis C Virus is constantly evolving genetically, particularly in response to the immune system. This is an observational study to examine if immunosuppressants particularly calcineurin inhibitors taken by transplant patients in order to avoid organ rejection causes predictable changes in the genetics of this virus that might be important in order to treat it effectively.

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2008-10
Est. Completion 2013-08

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT00819026

The ClinicalTrials.gov registry entry for NCT00819026 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00819026 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00819026 about?

NCT00819026 is a clinical study titled "Observational Trial of Hepatitis C Virus Infected Patients on Calcineurin Inhibitors". Hepatitis C Virus is constantly evolving genetically, particularly in response to the immune system. This is an observational study to examine if immunosuppressants particularly calcineurin inhibitors taken by transplant patients in order to avoid organ rejection causes predictable changes in the ge...

What is the current status of trial NCT00819026?

This trial is currently completed. The enrollment target is 15 participants. The study started on 2008-10. Estimated completion is 2013-08.

Who is sponsoring clinical trial NCT00819026?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.